A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer’s Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging

BACKGROUND: Small aggregates (oligomers) of the toxic proteins amyloid-β (Aβ) and phospho-tau (p-tau) are essential contributors to Alzheimer’s disease (AD). In mouse models for AD or human AD brain extracts, Transcranial Electromagnetic Treatment (TEMT) disaggregates both Aβ and p-tau oligomers, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Arendash, Gary, Cao, Chuanhai, Abulaban, Haitham, Baranowski, Rob, Wisniewski, Gary, Becerra, Lino, Andel, Ross, Lin, Xiaoyang, Zhang, Xiaolin, Wittwer, David, Moulton, Jay, Arrington, John, Smith, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839500/
https://www.ncbi.nlm.nih.gov/pubmed/31403948
http://dx.doi.org/10.3233/JAD-190367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839500/
https://www.ncbi.nlm.nih.gov/pubmed/31403948
http://dx.doi.org/10.3233/JAD-190367

Ejemplares similares